Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — April 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    gentogen
    wrote on sidst redigeret af
    #152

    A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Advanced Solid Tumors or Tumors That Have Spread.

    1 Reply Last reply
    0
    • G Offline
      G Offline
      gentogen
      wrote on sidst redigeret af
      #153

      Bristol-Myers Squibb

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #154

        301 Moved Permanently

        favicon

        (www.clinicaltrials.gov)

        1 Reply Last reply
        0
        • U Offline
          U Offline
          Unginvestor
          wrote on sidst redigeret af
          #155

          Tror i vi rammer 1250 inden en god nyhed? Synes der er lang tid til slut april efter de sidste par dage 😮

          1 Reply Last reply
          0
          • DarvinD Offline
            DarvinD Offline
            Darvin
            wrote on sidst redigeret af
            #156

            Tak Gentogen og hermed CD38 - PD-1 solide tumorer

            1 Reply Last reply
            0
            • DarvinD Offline
              DarvinD Offline
              Darvin
              wrote on sidst redigeret af
              #157

              Lidt gammel, feb 2017 - men Limo Chen i video om CD38 og PD-L1. Vi har jo læst artiklerne, men jeg havde ikke set videoen http://www.ascopost.com/videos/2017-asco-sitc-clinical-immuno-oncology-symposium/limo-chen-phd-on-lung-cancer-and-cd38-resistance-to-immunotherapy/

              1 Reply Last reply
              0
              • G Offline
                G Offline
                gentogen
                wrote on sidst redigeret af
                #158

                Jeg kan ikke følge med mere. er denne ikke ny? Open-label Trial of Daratumumab in Treatment of PGNIMD and C3 GN

                1 Reply Last reply
                0
                • G Offline
                  G Offline
                  gentogen
                  wrote on sidst redigeret af
                  #159

                  This is an inflammatory disease in the kidney due to the production of abnormal proteins. There are no known standard effective treatments for patients with PGNMID and C3GN secondary to monoclonal gammopathy. These diseases are caused by abnormal production of proteins (monoclonals) by abnormal clones

                  1 Reply Last reply
                  0
                  • G Offline
                    G Offline
                    gentogen
                    wrote on sidst redigeret af
                    #160

                    301 Moved Permanently

                    favicon

                    (www.clinicaltrials.gov)

                    1 Reply Last reply
                    0
                    • G Offline
                      G Offline
                      gentogen
                      wrote on sidst redigeret af
                      #161

                      Fernando Fervenza, Mayo Clinic

                      1 Reply Last reply
                      0
                      • DarvinD Offline
                        DarvinD Offline
                        Darvin
                        wrote on sidst redigeret af
                        #162

                        Jo tror også den er ny. Her er en artikel der diskuterer hvor Multi anvendelig Dara / CD38 er http://link.springer.com/article/10.1007%2Fs00262-017-1990-2

                        1 Reply Last reply
                        0
                        • BulderB Offline
                          BulderB Offline
                          Bulder
                          wrote on sidst redigeret af
                          #163

                          Begge helt nye, dog linkede E L til dem forleden.

                          1 Reply Last reply
                          0
                          • N Offline
                            N Offline
                            NextLifeDK
                            wrote on sidst redigeret af
                            #164

                            PGN; er det så almindelig nyrebetændelse er en slgs kræft?

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #165

                              Genmab annoncerede 5 januar at BMS med Nivolumumab (PD-1) og Dara skulle igangsætte forskellige studier m.h.p. solide tumorer. Så det er jo disse vi ser komme til verden.

                              1 Reply Last reply
                              0
                              • DarvinD Offline
                                DarvinD Offline
                                Darvin
                                wrote on sidst redigeret af
                                #166

                                Om forsøgene Fra Genmab: advanced or metastatic tumors including non-small cell lung, head and neck, pancreatic, colorectal and triple negative breast cancers. Additional tumor types may also be evaluated.

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #167

                                  Ah, så har vi Novods studie mid-17. Det er ikke Checkmate358 men Checkmate142, som er opdateret 29. marts. Der er nu primærdata juli 17. Så det er altså tyktarmskræft.

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #168

                                    301 Moved Permanently

                                    favicon

                                    (www.clinicaltrials.gov)

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JohnW
                                      wrote on sidst redigeret af
                                      #169

                                      Tyktarmskræft, hører denne kræftform under solide tumorer?

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #170

                                        Alt hvad der ikke er væsker eller plasma

                                        1 Reply Last reply
                                        0
                                        • E Offline
                                          E Offline
                                          E_L
                                          wrote on sidst redigeret af
                                          #171

                                          ah yes, the date,
                                          smart thinking Bulder 😉

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger